Extranodal lymphoma: A reappraisal

Annals of Oncology

Volumn 19, Issue SUPPL. 4, 2008, Pages

  Zucca, E ^a  

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; PREDNISONE; RITUXIMAB; VINCRISTINE; ANTINEOPLASTIC ANTIBIOTIC; ANTINEOPLASTIC ANTIMETABOLITE; CHOP PROTOCOL;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; BREAST LYMPHOMA; BREAST TUMOR; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; CLINICAL FEATURE; DISEASE COURSE; DRUG MEGADOSE; EXTRANODAL LYMPHOMA; GEOGRAPHIC DISTRIBUTION; HUMAN; INTRAVASCULAR B CELL LYMPHOMA; LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; ORCHIECTOMY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TESTIS LYMPHOMA; TESTIS TUMOR; TUMOR LOCALIZATION; CENTRAL NERVOUS SYSTEM TUMOR; FEMALE; FOLLOW UP; GASTROINTESTINAL TUMOR; MALE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROSPECTIVE STUDY; REMISSION; RETROSPECTIVE STUDY; REVIEW; STEM CELL TRANSPLANTATION; SURVIVAL; TREATMENT OUTCOME;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; METHOTREXATE; NEOPLASM STAGING; PREDNISONE; PROSPECTIVE STUDIES; REMISSION INDUCTION; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS; TREATMENT OUTCOME; VINCRISTINE;

EID: 48149105525     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn204     Document Type: Article

References (24)

1. Zucca E, Roggero E, Bertoni F et al. Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997; 8: 727-737.
2. Zucca E, Roggero E, Bertoni F et al. Primary extranodal non-Hodgkin's lymphomas. Part 2: Head and neck, central nervous system and other less common sites. Ann Oncol 1999; 10: 1023-1033.
3. Gospodarowicz MK, Ferry JA, Cavalli F. Unique aspects of primary extranodal lymphomas. In Mauch PM, Armitage JO, Harris NL et al.: Non-Hodgkin's Lymphomas. Philadelphia, PA: Lippincott Williams & Wilkins 2003; 685-707.
4. Groves FD, Linet MS, Travis LB et al. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000; 92: 1240-1251.
5. Krol AD, le Cessie S, Snijder S et al. Primary extranodal non-Hodgkin's lymphoma (NHL): The impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann Oncol 2003; 14: 131-139.
6. Chiu BC, Weisenburger DD. An update of the epidemiology of non-Hodgkin's lymphoma. Clin Lymphoma 2003; 4: 161-168.
7. Bertoni F, Zucca E. State-of-the-art therapeutics: Marginal-zone lymphoma. J Clin Oncol 2005; 23: 6415-6420.
8. Hancock B, Linch D, Delchier J et al. Chlorambucil versus observation after anti-Helicobacter therapy in low-grade gastric lymphoma: Results of the international LY03 trial (abstract). Ann Oncol 2005.
9. Zucca E, Conconi A, Pedrinis E et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003; 101: 2489-2495.
10. Cortelazzo S, Rossi A, Oldani E et al. The modified International Prognostic Index can predict the outcome of localized primary intestinal lymphoma of both extranodal marginal zone B-cell and diffuse large B-cell histologies. Br J Haematol 2002; 118: 218-228.
11. Cortelazzo S, Rossi A, Roggero F et al. Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG). Ann Oncol 1999; 10: 1433-1440.
12. Christie D, Gracia E, Gospodarowicz M et al. Patterns of outcome and prognostic factors in primary bone lymphoma (osteolymphoma): A survey of 499 cases by the International Extranodal Lymphoma Study Group. Haematologica 2007; 92 (Suppl 1): Abstr 0717.
13. Ryan G, Martinelli G, Kuper-Hommel M et al. Primary diffuse large B-cell lymphoma of the breast: Prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ann Oncol 2008; 19: 233-241.
14. Zucca E, Conconi A, Mughal TI et al. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol 2003; 21: 20-27.
15. Ferreri AJ, Blay JY, Reni M et al. Prognostic scoring system for primary CNS lymphomas: The International Extranodal Lymphoma Study Group experience. J Clin Oncol 2003; 21: 266-272.
16. Zucca E, Bertoni F, Roggero E et al. The gastric marginal zone B-cell lymphoma of MALT type. Blood 2000; 96: 410-419.
17. Pinotti G, Zucca E, Roggero E et al. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 1997; 26: 527-537.
18. Thieblemont C, Berger F, Dumontet C et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000; 95: 802-806.
19. Ferreri AJ, Dognini GP, Campo E et al. Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. Haematologica 2007; 92: 486-492.
20. Ferreri AJ, Campo E, Seymour JF et al. Intravascular lymphoma: Clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'. Br J Haematol 2004; 127: 173-183.
21. Murase T, Yamaguchi M, Suzuki R et al. Intravascular large B-cell lymphoma (IVLBCL): A clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 2007; 109: 478-485.
22. Ponzoni M, Ferreri AJ, Campo E et al. Definition, diagnosis, and management of intravascular large B-cell lymphoma: Proposals and perspectives from an international consensus meeting. J Clin Oncol 2007; 25: 3168-3173.
23. Ferreri AJ, Campo E, Ambrosetti A et al. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol 2004; 15: 1215-1221.
24. Vitolo U, Zucca E, Martelli M et al. Primary diffuse large B-cell lymphoma of the testis (PTL): A prospective study of rituximab (R)-CHOP with CNS and contralateral testis prophylaxis. Results of the IELSG 10 study. Blood 2006 (ASH Annual Meeting Abstracts): (Abstr 208).